Webinar: Can AI Replace Humans in Pharmacovigilance?
In October 2024, we hosted a roundtable discussion on artificial intelligence (AI) in pharmacovigilance (PV) at the World Safety Conference in Boston. The session sparked insightful conversations and drew a strong audience of delegates eager to participate or listen.
During the discussion, we explored the benefits of AI, such as reducing data entry errors, saving time when creating cases in safety databases, and improving accuracy in listings and summary tabulations. We also addressed key challenges, including software costs, data security concerns, programming errors, and the lack of specific regulations governing AI use in pharmacovigilance.
Unfortunately, time ran out before we could cover everything. However, many attendees expressed a strong interest in continuing the conversation—so that’s exactly what we did during this this webinar roundtable discussion!
Interested in finding out more about our pharmacovigilance services and solutions?
Contact us to see how our experts can support you with strategies to enhance patient safety and mitigate risks throughout the product lifecycle.
